Published in Bull World Health Organ on December 01, 2008
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol (2014) 2.88
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet (2016) 2.44
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation (2013) 2.31
National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr (2011) 1.81
Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med (2012) 1.70
Secular trends in BMI and blood pressure among children and adolescents: the Bogalusa Heart Study. Pediatrics (2012) 1.28
Increasing prevalence of type 2 diabetes in a rural bangladeshi population: a population based study for 10 years. Diabetes Metab J (2013) 1.26
Use of instrumental variable in prescription drug research with observational data: a systematic review. J Clin Epidemiol (2010) 1.03
Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol (2015) 1.00
Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey. PLoS One (2016) 0.86
Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011. Int J Clin Exp Med (2015) 0.82
Secular trends of the impact of overweight and obesity on hypertension in Japan, 1980-2010. Hypertens Res (2015) 0.81
Dementia and lower blood pressure in Latin America, India, and China: a 10/66 cross-cohort study. Neurology (2013) 0.81
Dietary factors related to hypertension risk in Korean adults-data from the Korean national health and nutrition examination survey III. Nutr Res Pract (2011) 0.80
Sociodemographic correlates of four indices of blood pressure and hypertension among older persons in Japan. Gerontology (2013) 0.78
The nine-year changes of the incidence and characteristics of metabolic syndrome in China: longitudinal comparisons of the two cross-sectional surveys in a newly formed urban community. Cardiovasc Diabetol (2016) 0.77
Change in the association of body mass index and systolic blood pressure in Germany - national cross-sectional surveys 1998 and 2008-2011. BMC Public Health (2015) 0.77
Factors associated with untreated diabetes: analysis of data from 20,496 participants in the Japanese national health and nutrition survey. PLoS One (2015) 0.76
Estimating change in cardiovascular disease and diabetes burdens due to dietary and metabolic factors in Korea 1998-2011: a comparative risk assessment analysis. BMJ Open (2016) 0.75
Secondary Data Analysis of National Surveys in Japan Toward Improving Population Health. J Epidemiol (2016) 0.75
The effect of hypertension and diabetes management in Southwest China: a before- and after-intervention study. PLoS One (2014) 0.75
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA (2003) 14.77
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension (2006) 11.68
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ (2003) 8.55
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension (1995) 6.48
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet (2006) 3.60
Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev (2002) 2.35
Blood pressure and stroke: an overview of published reviews. Stroke (2004) 2.21
The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr (1997) 1.97
Association between smoking and blood pressure: evidence from the health survey for England. Hypertension (2001) 1.82
Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80). J Hypertens (2006) 1.65
A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens (2005) 1.55
Thinness among young Japanese women. Am J Public Health (2004) 1.37
Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens Suppl (1999) 1.20
Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res (2006) 1.18
Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989. Int J Epidemiol (1993) 1.16
Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res (2006) 1.16
National Nutrition Survey in Japan--its methodological transition and current findings. J Nutr Sci Vitaminol (Tokyo) (2002) 1.06
Physical activity in the prevention and treatment of hypertension in the obese. Med Sci Sports Exerc (1999) 1.06
Declining trends in blood pressure level and the prevalence of hypertension, and changes in related factors in Japan, 1956-1980. J Chronic Dis (1987) 1.01
Birth cohort evidence of population influences on blood pressure in the United States, 1887-1994. Ann Epidemiol (2001) 0.98
Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med (2002) 0.95
Trends of average intake of macronutrients in 47 prefectures of Japan from 1975 to 1994--possible factors that may bias the trend data. J Epidemiol (1998) 0.94
Changes in cardiovascular disease risk factors in three Japanese national surveys 1971-1990. J Epidemiol (1996) 0.91
Guidelines for the management of hypertension for general practitioners. Hypertens Res (2001) 0.87
Is the national nutrition survey in Japan representative of the entire Japanese population? Nutrition (2005) 0.83
Current status of antihypertensive therapy for elderly patients in Japan. Hypertens Res (1996) 0.82
[Guidelines on treatment of hypertension in the elderly, 1995--a tentative plan for comprehensive research projects on aging and health-- Members of the Research Group for "Guidelines on Treatment of Hypertension in the Elderly", Comprehensive Research Projects on Aging and Health, the Ministry of Health and Welfare of Japan]. Nihon Ronen Igakkai Zasshi (1996) 0.79
Current status of calcium antagonists in Japan. Am J Cardiol (1998) 0.79
Guidelines for hypertension in the elderly--1999 revised version. Ministry of Health and Welfare of Japan. Hypertens Res (1999) 0.79
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Household catastrophic health expenditure: a multicountry analysis. Lancet (2003) 20.07
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet (2009) 13.41
Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Public financing of health in developing countries: a cross-national systematic analysis. Lancet (2010) 11.22
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: an impact evaluation. Lancet (2010) 9.90
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63
Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med (2006) 6.11
Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med (2013) 6.04
Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet (2010) 5.36
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Public policy for the poor? A randomised assessment of the Mexican universal health insurance programme. Lancet (2009) 5.23
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet (2007) 4.15
Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ (2004) 3.94
A systematic analysis of global anemia burden from 1990 to 2010. Blood (2013) 3.94
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89
The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Med (2008) 3.73
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (2013) 3.65
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
Strengthening health information systems to address health equity challenges. Bull World Health Organ (2005) 3.46
WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ (2003) 3.42
Assessment of population-level effect of Avahan, an HIV-prevention initiative in India. Lancet (2011) 3.39
Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet (2006) 3.33
Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med (2011) 3.32
Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer (2002) 3.26
Benchmarking of performance of Mexican states with effective coverage. Lancet (2006) 3.06
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.99
Limitations of methods for measuring out-of-pocket and catastrophic private health expenditures. Bull World Health Organ (2009) 2.89
Are Americans feeling less healthy? The puzzle of trends in self-rated health. Am J Epidemiol (2009) 2.88
Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med (2004) 2.84
Access, utilization, quality, and effective coverage: an integrated conceptual framework and measurement strategy. Soc Sci Med (2005) 2.78
Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation. Lancet (2006) 2.67
The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS (2013) 2.66
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.66
Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation (2008) 2.65
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet (2011) 2.61
Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med (2005) 2.40
China's health system performance. Lancet (2008) 2.36
Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment. Lancet (2006) 2.35
Measuring adult mortality using sibling survival: a new analytical method and new results for 44 countries, 1974-2006. PLoS Med (2010) 2.32
Reductions in child mortality levels and inequalities in Thailand: analysis of two censuses. Lancet (2007) 2.30
The burden of disease and injury in the United States 1996. Popul Health Metr (2006) 2.27
Global health development assistance remained steady in 2013 but did not align with recipients' disease burden. Health Aff (Millwood) (2014) 2.26
The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Aff (Millwood) (2011) 2.21
Measuring under-five mortality: validation of new low-cost methods. PLoS Med (2010) 2.14
A multi-method approach to measuring health-state valuations. Health Econ (2004) 2.10
Should data from demographic surveillance systems be made more widely available to researchers? PLoS Med (2008) 2.06
Developing a comprehensive time series of GDP per capita for 210 countries from 1950 to 2015. Popul Health Metr (2012) 1.95
A "politically robust" experimental design for public policy evaluation, with application to the Mexican universal health insurance program. J Policy Anal Manage (2007) 1.94
Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ (2010) 1.84
Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One (2013) 1.81
The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Med (2010) 1.78
Has the DOTS strategy improved case finding or treatment success? An empirical assessment. PLoS One (2008) 1.74
Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med (2015) 1.70
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med (2014) 1.66
Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs. J Infect Dis (2012) 1.65
Fifty years of violent war deaths from Vietnam to Bosnia: analysis of data from the world health survey programme. BMJ (2008) 1.61
Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ (2007) 1.60
Nets, spray or both? The effectiveness of insecticide-treated nets and indoor residual spraying in reducing malaria morbidity and child mortality in sub-Saharan Africa. Malar J (2013) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries. Bull World Health Organ (2010) 1.44
Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr (2011) 1.43
Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site. BMC Cancer (2002) 1.31
Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob Heart (2012) 1.26